Dec. 31, 2021– Today is the final day of what might be one of the most eventful years in the history of the 340B drug pricing program. Key developments in the 340B world stood out even amid all the news about a global pandemic, a change in leadership in Washington, and an uneasy economic climate. As we wrap up 2021 and look forward to a new year, we are reflecting on some of … [Read more...]
A Hospital Community United Against Threats to 340B
Dec. 20, 2021— Hundreds of safety-net hospitals are urging the federal government to escalate its efforts to stop a group of drug companies that are refusing to offer drug discounts that the federal 340B drug pricing program requires. Today, more than 800 hospitals participating in 340B sent a letter to Health and Human Services (HHS) Secretary Xavier Becerra calling on the … [Read more...]
340B Providers Contemplate the Challenges Met and Prepare for the Ones Ahead
By Maureen Testoni March 11, 2021– In this pandemic-focused world we all find ourselves in, it seems only fitting that one of my highlights of this past month was getting the chance to meet Fauci. No, I’m not talking about the esteemed Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, who has become a household name over the past … [Read more...]
Government Opinion Paves the Way for Reversal of Drug Company Refusals to Provide 340B Discounts
Jan. 8, 2021– While many of us were preparing for an untraditional New Year’s Eve celebration, the federal government made a vitally important announcement about 340B. The administration unequivocally stated that drug companies denying 340B discounts to hospitals, health centers, and clinics that partner with community pharmacies are in violation of federal law. In an … [Read more...]
340B Key to Trump Administration’s HIV Strategy
April 25, 2019— President Trump’s ambitious campaign to end the HIV epidemic in the U.S. will rely heavily on the 340B drug pricing program, according to senior administration officials. A key focus of the effort is to connect people at risk of HIV infection to pre-exposure prophylaxis (PrEP), a treatment that can cost nearly $2,000 a month. In his State of the Union … [Read more...]
Busy times for 340B in Washington
November 19, 2018—The midterm elections were not the only source of Washington-related news in recent weeks with implications for the health care system. When it comes to 340B, several key events occurred in the days leading up to Election Day that might have longer-lasting implications for the program than the makeup of the 116th Congress. White House thinks globally on … [Read more...]
340B Health and Other Groups Sue HHS Challenging Delay of 340B Regulation
September 11, 2018—Today, 340B Health and three other national hospital associations have filed suit to force the U.S. Department of Health and Human Services (HHS) to enforce rules prohibiting manufacturers from overcharging 340B providers. The suit also would compel HHS to post 340B ceiling prices on a secure website. In 2010, Congress responded to a series of reports by … [Read more...]